Related Experiment Video
Updated: Mar 15, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Ebola virus disease and the eye
Jessica G Shantha1, Steven Yeh, Quan Dong Nguyen
1aDepartment of Ophthalmology, Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California bDepartment of Ophthalmology, Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia cOcular Imaging Research and Reading Center, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Ebola virus disease (EVD) can cause serious eye problems during acute infection and recovery. Ophthalmic complications, like uveitis, significantly impact survivors
Area of Science:
- Ophthalmology
- Infectious Diseases
- Public Health
Background:
- The 2014-2016 West Africa Ebola virus disease (EVD) epidemic highlighted significant health challenges in survivors.
- Systemic and ocular complications are increasingly reported in individuals who recover from EVD.
Purpose of the Study:
- To review and summarize the ophthalmic complications associated with Ebolavirus infection.
- To understand the spectrum of eye diseases in EVD survivors.
Main Methods:
- Literature review of ophthalmic complications in Ebola virus disease.
- Analysis of reported cases and clinical manifestations.
Main Results:
- EVD can lead to ocular manifestations during both acute infection and the convalescent phase.
- Acute EVD patients may present with conjunctivitis, subconjunctival hemorrhages, and vision loss.
- Uveitis is a common complication during recovery, with live virus implicated in one case.
Conclusions:
- Ophthalmic complications are a critical aspect of EVD survivorship, affecting functional status and economic well-being.
- Further research is essential to fully characterize and manage the spectrum of eye diseases in EVD survivors.
- Developing targeted studies and programs is crucial for this at-risk population.
Related Concept Videos
Cross-reactivity
Accessory Structures of the Eye
Glaucoma: Overview

